NUVA up +2.64% percent Today $NUVA High is at 44.5
Post# of 51
Posted On: 11/11/2014 1:31:35 PM
NUVA up +2.64% percent Today $NUVA High is at 44.50 and the Low 42.46 with current volume of 244,607.
Recent News posted below.
Nuvasive Inc NUVA other info.
http://investorshangout.com/NuVasive-Inc-NUVA-54931/
NUVA Nuvasive Inc Recent Headline News
NuVasive(R) Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting
Marketwired - Mon Nov 10, 3:07PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive or the "Company"
, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29th North American Spine Society ("NASS" Annual Meeting, held November 12-15, 2014, at the Moscone Center in San Francisco, CA. The Company's attendance underscores NuVasive's ongoing commitment to surgeon support through numerous educational workshops and the exhibition of several of the Company's products and procedures that have revolutionized the spine industry.
NUVA: 43.10 (+0.63)
NuVasive Has Returned 18.5% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 12:55PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 5 months, NuVasive has returned 18.46% as of today's recent price of $42.25.
NUVA: 43.10 (+0.63)
NuVasive Earnings Hindsight: Up 6.3% in Last 11 Days (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 11:41AM CST
11 days ago, on October 30th, 2014, NuVasive (NASDAQ:NUVA) reported its earnings. Analysts, on average, expected earnings of $0.25 per share on sales of $179.1 million. NuVasive actually reported earnings of $0.19 per share on sales of $189.9 million, missing EPS estimates by $0.06 and beating revenue estimates by $10.9 million. Since the company's report, shares of NuVasive have risen from $39.26 to $41.75, representing a gain of 6.3% in the past 11 days.
NUVA: 43.10 (+0.63)
Could This Obamacare Tax Be Repealed?
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 7:18AM CST
Source: White House on Flickr. With the midterm elections now in the rear-view mirror, Americans can begin speculating about the policies that will come out of Washington over the next two years. Personally, I can't say I'm a huge fan of the...
ZMH: 110.93 (+0.51), BSX: 13.29 (-0.16), MDT: 68.71 (unch), NUVA: 43.10 (+0.63)
Update: NuVasive Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Fri Nov 07, 3:09PM CST
NUVA: 43.10 (+0.63)
Insider Trading Alert - SANM, NUVA And EMC Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include SANM, NUVA and EMC
EMC: 29.06 (-0.10), NUVA: 43.10 (+0.63), SANM: 25.50 (+0.11)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 141.19 (+0.37), LMT: 186.93 (-0.06), MDT: 68.71 (unch), QDEL: 28.30 (+0.28), XOM: 96.27 (-0.01), CLF: 10.79 (-0.25), BA: 125.27 (+0.63), NUVA: 43.10 (+0.63), ANR: 2.58 (-0.06), BSX: 13.29 (-0.16), VLO: 51.15 (+0.56), BTU: 11.12 (-0.28), ABAX: 53.09 (+0.15), IMO: 47.59 (+0.09), ACI: 2.39 (-0.12)
NuVasive to Host Investor Morning on November 13, 2014
Marketwired - Mon Nov 03, 3:09PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company" , a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will host a meeting for investors and analysts on Thursday, November 13, 2014 from 8:00 a.m. to 10:00 a.m. PT at the W Hotel in San Francisco, California.
NUVA: 43.10 (+0.63)
NuVasive Shares Up 16.2% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 03, 9:57AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 4 months, NuVasive has returned 16.22% as of today's recent price of $41.45.
NUVA: 43.10 (+0.63)
NuVasive spikes 3.8% after guidance update
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:15PM CDT
NUVA: 43.10 (+0.63)
NuVasive's (NUVA) CEO Alex Lukianov on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 12:15AM CDT
NUVA: 43.10 (+0.63)
NuVasive (NUVA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:25PM CDT
NUVA: 43.10 (+0.63)
NuVasive misses by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:43PM CDT
NUVA: 43.10 (+0.63)
NuVasive Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance
Marketwired - Thu Oct 30, 3:07PM CDT
NuVasive, Inc. (NASDAQ: NUVA)
NUVA: 43.10 (+0.63)
NuVasive Announces Conference Call and Webcast of Third Quarter 2014 Results
Marketwired - Thu Oct 16, 3:30PM CDT
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its third quarter 2014 earnings announcement will take place on Thursday, October 30, 2014, after the close of the market.
NUVA: 43.10 (+0.63)
Insider Trading Alert - REX, NVAX And NUVA Traded By Insiders
at The Street - Tue Oct 07, 10:54AM CDT
Stocks with insider trader activity include REX, NVAX and NUVA
NVAX: 5.32 (+0.11), REX: 68.50 (-2.64), NUVA: 43.10 (+0.63)
NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and Innovative Product Exhibition
Thomson Reuters ONE - Wed Oct 01, 7:31AM CDT
Product Demonstrations and Spine Procedure Workshops Highlight Commitment to Serving the Needs of Patients and Surgeons in Europe; Company Also Announces Opening of New European Center of Excellence in Amsterdam
NUVA: 43.10 (+0.63)
Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today?
at The Street - Tue Sep 30, 8:31AM CDT
Brean Capital upgraded NuVasive (NUVA) to 'buy' from 'hold' and set a $44 price target.
NUVA: 43.10 (+0.63)
Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Tue Sep 30, 7:07AM CDT
NuVasive (NASDAQ:NUVA) was upgraded from Hold to Buy at Brean Capital today. The stock closed yesterday at $35.02 on volume of 139,000 shares, below average daily volume of 256,000. NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
NUVA: 43.10 (+0.63)
Recent News posted below.
Nuvasive Inc NUVA other info.
http://investorshangout.com/NuVasive-Inc-NUVA-54931/
NUVA Nuvasive Inc Recent Headline News
NuVasive(R) Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting
Marketwired - Mon Nov 10, 3:07PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive or the "Company"
, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29th North American Spine Society ("NASS" Annual Meeting, held November 12-15, 2014, at the Moscone Center in San Francisco, CA. The Company's attendance underscores NuVasive's ongoing commitment to surgeon support through numerous educational workshops and the exhibition of several of the Company's products and procedures that have revolutionized the spine industry. NUVA: 43.10 (+0.63)
NuVasive Has Returned 18.5% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 12:55PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 5 months, NuVasive has returned 18.46% as of today's recent price of $42.25.
NUVA: 43.10 (+0.63)
NuVasive Earnings Hindsight: Up 6.3% in Last 11 Days (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 11:41AM CST
11 days ago, on October 30th, 2014, NuVasive (NASDAQ:NUVA) reported its earnings. Analysts, on average, expected earnings of $0.25 per share on sales of $179.1 million. NuVasive actually reported earnings of $0.19 per share on sales of $189.9 million, missing EPS estimates by $0.06 and beating revenue estimates by $10.9 million. Since the company's report, shares of NuVasive have risen from $39.26 to $41.75, representing a gain of 6.3% in the past 11 days.
NUVA: 43.10 (+0.63)
Could This Obamacare Tax Be Repealed?
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 7:18AM CST
Source: White House on Flickr. With the midterm elections now in the rear-view mirror, Americans can begin speculating about the policies that will come out of Washington over the next two years. Personally, I can't say I'm a huge fan of the...
ZMH: 110.93 (+0.51), BSX: 13.29 (-0.16), MDT: 68.71 (unch), NUVA: 43.10 (+0.63)
Update: NuVasive Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Fri Nov 07, 3:09PM CST
NUVA: 43.10 (+0.63)
Insider Trading Alert - SANM, NUVA And EMC Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include SANM, NUVA and EMC
EMC: 29.06 (-0.10), NUVA: 43.10 (+0.63), SANM: 25.50 (+0.11)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 141.19 (+0.37), LMT: 186.93 (-0.06), MDT: 68.71 (unch), QDEL: 28.30 (+0.28), XOM: 96.27 (-0.01), CLF: 10.79 (-0.25), BA: 125.27 (+0.63), NUVA: 43.10 (+0.63), ANR: 2.58 (-0.06), BSX: 13.29 (-0.16), VLO: 51.15 (+0.56), BTU: 11.12 (-0.28), ABAX: 53.09 (+0.15), IMO: 47.59 (+0.09), ACI: 2.39 (-0.12)
NuVasive to Host Investor Morning on November 13, 2014
Marketwired - Mon Nov 03, 3:09PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company"
, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will host a meeting for investors and analysts on Thursday, November 13, 2014 from 8:00 a.m. to 10:00 a.m. PT at the W Hotel in San Francisco, California. NUVA: 43.10 (+0.63)
NuVasive Shares Up 16.2% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 03, 9:57AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 4 months, NuVasive has returned 16.22% as of today's recent price of $41.45.
NUVA: 43.10 (+0.63)
NuVasive spikes 3.8% after guidance update
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:15PM CDT
NUVA: 43.10 (+0.63)
NuVasive's (NUVA) CEO Alex Lukianov on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 12:15AM CDT
NUVA: 43.10 (+0.63)
NuVasive (NUVA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:25PM CDT
NUVA: 43.10 (+0.63)
NuVasive misses by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:43PM CDT
NUVA: 43.10 (+0.63)
NuVasive Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance
Marketwired - Thu Oct 30, 3:07PM CDT
NuVasive, Inc. (NASDAQ: NUVA)
NUVA: 43.10 (+0.63)
NuVasive Announces Conference Call and Webcast of Third Quarter 2014 Results
Marketwired - Thu Oct 16, 3:30PM CDT
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its third quarter 2014 earnings announcement will take place on Thursday, October 30, 2014, after the close of the market.
NUVA: 43.10 (+0.63)
Insider Trading Alert - REX, NVAX And NUVA Traded By Insiders
at The Street - Tue Oct 07, 10:54AM CDT
Stocks with insider trader activity include REX, NVAX and NUVA
NVAX: 5.32 (+0.11), REX: 68.50 (-2.64), NUVA: 43.10 (+0.63)
NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and Innovative Product Exhibition
Thomson Reuters ONE - Wed Oct 01, 7:31AM CDT
Product Demonstrations and Spine Procedure Workshops Highlight Commitment to Serving the Needs of Patients and Surgeons in Europe; Company Also Announces Opening of New European Center of Excellence in Amsterdam
NUVA: 43.10 (+0.63)
Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today?
at The Street - Tue Sep 30, 8:31AM CDT
Brean Capital upgraded NuVasive (NUVA) to 'buy' from 'hold' and set a $44 price target.
NUVA: 43.10 (+0.63)
Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Tue Sep 30, 7:07AM CDT
NuVasive (NASDAQ:NUVA) was upgraded from Hold to Buy at Brean Capital today. The stock closed yesterday at $35.02 on volume of 139,000 shares, below average daily volume of 256,000. NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
NUVA: 43.10 (+0.63)
(0)
(0)NuVasive Inc. (NUVA) Stock Research Links
Scroll down for more posts ▼